08 September 2021 | NewsCOVID-19 Delta variant in schools and early childhood education and care services in NSW, Australia: 16 June to 31 July 2021Read the full article
This webinar was held as part of the 2021 NCIRS COVID-19 vaccine webinar series.
View the video of this webinar to:
Our expert panel members also answered several vaccine questions asked by the attendees.
Professor (Practice) Alison J McMillan
Chief Nursing and Midwifery Officer, Australian Government Department of Health
Alison McMillan is Chief Nursing and Midwifery Officer, Australian Government Department of Health. Alison is a registered nurse with a Critical Care Nursing Certificate, a Bachelor of Education and a Master of Business Administration. She was awarded the National Emergency Medal in recognition of service following the 2009 Victorian bushfires.
Alison is an experienced executive manager with more than 30 years’ experience across the public health system. Alison has held senior executive roles in government and health services in Victoria, including the Chief Nursing and Midwifery Officer and Director of Quality, Safety and Patient Experience.
Alison is a member of the Australian Health Protection Principal Committee, contributing to key advice provided to the National Cabinet during the COVID-19 pandemic, and, as Co-Chair of the Infection Control Expert Group, provides advice and information on best practice on infection prevention and control in the community, hospitals, aged care, schools and community sport.
Associate Professor Sheena Sullivan
Head of Epidemiology, World Health Organisation (WHO) Collaborating Centre for Reference and Research on Influenza
Sheena Sullivan is head of epidemiology at the WHO Collaborating Centre for Reference and Research on Influenza. She works with sentinel surveillance programs in Australia and abroad to estimate influenza vaccine effectiveness, quantify bias in vaccine studies, and burden of influenza and other respiratory viruses.
She leads or collaborates on several sero-epidemiological cohort studies to characterise responses to influenza infection and vaccination.
Professor Allen Cheng
Director of Infection Prevention and Healthcare Epidemiology, Alfred Health, Professor in Infectious Diseases Epidemiology, Chair of the Advisory Committee for Vaccines
Allen Cheng is an infectious diseases physician. He is Professor of Infectious Diseases Epidemiology and Director of the Infection Prevention and Healthcare Epidemiology unit at Alfred Health. He has a PhD (Flinders University), a Master of Public Health (Monash University) and a Master of Biostatistics (University of Queensland).
Allen has previously worked as an infectious diseases and general physician in Darwin and Geelong, and has worked in remote communities in the Top End of Australia, and globally in Papua New Guinea, Thailand, the United States and Finland.
He is the current Chair of the Advisory Committee for Vaccines and a previous member of the Advisory Committee on Prescription Medicines (advising the Therapeutic Goods Administration on vaccine and drug regulation issues), and Co-Chair of the Australian Technical Group on Immunisation (ATAGI). He is also a member of the National Influenza Surveillance Committee.
Also hear from:
NCIRS, Kids Research, Sydney Children’s Hospitals Network, Cnr Hawkesbury Rd & Hainsworth St, Westmead Locked Bag 4001, Westmead NSW 2145 Tel (612) 9845 1433 | Fax (612) 9845 1418 | ABN 53 188 579 090
We acknowledge that the National Centre for Immunisation Research and Surveillance (NCIRS) is on the land of the traditional owners the Aboriginal and Torres Strait Islander peoples, the First Australians, and recognise their culture, history, diversity and their deep connection to the land. Together, through research and partnership, we aim to move to a place of equity for all. NCIRS also acknowledges and pays respect to other Aboriginal and Torres Strait Islander nations from which our research, staff and community are drawn.
Copyright © 2021 NCIRS. All rights reserved
Our website meets the criteria for credibility and content as defined by the Global Advisory Committee on Vaccine Safety.
Stay updated with the latest from NCIRS